Suman Akand; Dbarta24 — Despite being an agrarian economy where pesticides are vital for crop yields, Bangladesh remains heavily dependent on chemical imports.
Long-standing influence by importers, policy discrimination, and bureaucratic hurdles are actively preventing the growth of a robust domestic pesticide manufacturing industry, experts and industry insiders reveal.
This entrenched import dependency not only escalates production costs for local farmers but also places an unnecessary burden on the nation’s foreign exchange reserves.
The Legacy of Import Monopolies
The origin of this market imbalance dates back to the post-independence era, when a small group of traders began importing pesticides to supply the domestic market.
In 1979, these traders formed the Pesticide Association, now known as the Bangladesh Crop Protection Association (BCPA). Today, BCPA boasts approximately 1,400 members and remains largely dominated by import-focused businesses.
Pesticide manufacturers draw a stark comparison with the domestic pharmaceutical sector to highlight what policy support could achieve.
Proper governmental incentives enabled Bangladesh’s pharmaceutical industry to flourish, with local manufacturers now meeting nearly 96% of domestic demand and exporting high-tech products—including insulin, hormone therapies, and oncology drugs—to over 160 countries.
Conversely, the nation’s pesticide market, valued at over BDT 5,000 crore annually with usage surging nearly tenfold over the past five decades, remains trapped in import reliance despite requiring comparatively simpler technology.
Local Manufacturers Facing Severe Regulatory Barriers
In 2022, twenty local companies established the Bangladesh Agrochemical Manufacturers Association (BAMA) to foster a self-reliant manufacturing sector.
BAMA members import raw active ingredients and formulate pesticides locally within their own factories and quality-control laboratories.
However, manufacturers assert that entrenched import interests and restrictive policy frameworks severely handicap their efforts.
Raw material procurement is currently hindered by three primary regulatory traps:
-
Registration Discrepancies: Regulations mandate that imported materials belong to a registered pesticide. However, current laws only accommodate the registration of finished products, leaving raw active ingredients without a clear legal pathway for registration.
-
Impractical Field Trials: Authorities demand field trials prior to raw material imports—a requirement that is technically impossible since raw active ingredients are intermediate inputs rather than end-user products.
-
Restricted Sourcing: Strict requirements enforcing specific sourcing origins limit local manufacturers from procuring raw materials at competitive rates on the open international market, inflating production costs and creating supply chain uncertainties.
Institutional Conflict and Divergent Interests
Tensions between the importer-dominated BCPA and the manufacturing-focused BAMA have escalated into an institutional dispute over market control and policy direction.
Establishing a manufacturing plant demands massive capital investment in advanced production lines, quality-control testing, environmental safeguards, and specialized labor. Importers, by contrast, operate with minimal infrastructure while selling imported finished goods at premium prices.
BAMA alleges that BCPA went as far as petitioning the Ministry of Commerce to cancel BAMA’s organizational license in an attempt to stifle local industry growth—a matter that remains pending resolution.
“We want to deliver affordable pesticides directly to our farmers,” stated Agronomist K.S.M. Mostafizur Rahman, President of BAMA. “We are actively working toward this goal, but certain vested interest groups still do not want domestic production to expand.”
Rahman emphasized that Bangladesh should aim not only to satisfy domestic demand but also to establish raw material formulation hubs capable of exporting agrochemicals abroad.
Concerns have also been raised over regulatory oversight: in 2005, the Pesticide Technical Advisory Committee (PITAC) approved 600 pesticide formulations, but that figure surged to 1,086 approved products in a single meeting in 2023, raising questions regarding the thoroughness of the vetting process.
Offering the importers’ perspective, Md. Mehedi Hasan Pathan Shamim, General Secretary of BCPA, pointed to environmental considerations.
“Pesticide manufacturing in Bangladesh is possible, but environmental risks must be factored in,” Shamim noted. “We must carefully weigh whether the economic gains outweigh potential environmental degradation. Nevertheless, we also wish to move toward domestic manufacturing.”
Strengthening Research Infrastructure for Policy Protection
Addressing the industry’s structural bottlenecks, Dr. Rashedul Islam, Vice-Chancellor and Entomologist at Kurigram Agricultural University, emphasized the need for academic and technological investment.
“Bangladesh certainly possesses the technical capacity to manufacture pesticides,” Dr. Islam observed. “However, we must strengthen our research infrastructure to support new product innovation, ensure quality control, and secure international-grade patents.”
Dr. Islam further cautioned that expanding domestic production threatens the commercial interests of major pesticide-exporting countries, which may attempt to protect their market share.
Consequently, he urged the government to implement strong policy safeguards to shield Bangladesh’s nascent manufacturing industry from unfair international competition.